These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 20640803)
1. Computational modeling study of human nicotinic acetylcholine receptor for developing new drugs in the treatment of alcoholism. Hu ZJ; Bai L; Tizabi Y; Southerland W Interdiscip Sci; 2009 Dec; 1(4):254-62. PubMed ID: 20640803 [TBL] [Abstract][Full Text] [Related]
2. Model of the extracellular domain of the human alpha7 nAChR based on the crystal structure of the mouse alpha1 nAChR extracellular domain. Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E J Mol Graph Model; 2008 Jun; 26(8):1333-7. PubMed ID: 18329305 [TBL] [Abstract][Full Text] [Related]
3. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties. Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of Dalpha6 and Dalpha7 nicotinic acetylcholine receptor subunits from Drosophila: formation of a high-affinity alpha-bungarotoxin binding site revealed by expression of subunit chimeras. Lansdell SJ; Millar NS J Neurochem; 2004 Jul; 90(2):479-89. PubMed ID: 15228604 [TBL] [Abstract][Full Text] [Related]
5. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions. Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149 [TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors. Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616 [TBL] [Abstract][Full Text] [Related]
7. Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras. Papke RL; Dwoskin LP; Crooks PA; Zheng G; Zhang Z; McIntosh JM; Stokes C Neuropharmacology; 2008 Jun; 54(8):1189-200. PubMed ID: 18448138 [TBL] [Abstract][Full Text] [Related]
8. Computational approaches to understand alpha-conotoxin interactions at neuronal nicotinic receptors. Dutertre S; Lewis RJ Eur J Biochem; 2004 Jun; 271(12):2327-34. PubMed ID: 15182348 [TBL] [Abstract][Full Text] [Related]
9. Rational understanding of nicotinic receptors drug binding. Grutter T; Le Novère N; Changeux JP Curr Top Med Chem; 2004; 4(6):645-50. PubMed ID: 14965300 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of α-conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists. Banerjee J; Yongye AB; Chang YP; Gyanda R; Medina-Franco JL; Armishaw CJ Biopolymers; 2014 Jan; 102(1):78-87. PubMed ID: 24122487 [TBL] [Abstract][Full Text] [Related]
11. In search of allosteric modulators of a7-nAChR by solvent density guided virtual screening. Dey R; Chen L J Biomol Struct Dyn; 2011 Apr; 28(5):695-715. PubMed ID: 21294583 [TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of human pentameric alpha(7) neuronal nicotinic acetylcholine receptor and its interaction with its agonist and competitive antagonist. Parthiban M; Rajasekaran MB; Ramakumar S; Shanmughavel P J Biomol Struct Dyn; 2009 Apr; 26(5):535-47. PubMed ID: 19236104 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly: Ligand-bound α2 homopentamer. Kouvatsos N; Giastas P; Chroni-Tzartou D; Poulopoulou C; Tzartos SJ Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9635-40. PubMed ID: 27493220 [TBL] [Abstract][Full Text] [Related]
15. Identification of N-terminal extracellular domain determinants in nicotinic acetylcholine receptor (nAChR) α6 subunits that influence effects of wild-type or mutant β3 subunits on function of α6β2*- or α6β4*-nAChR. Dash B; Bhakta M; Chang Y; Lukas RJ J Biol Chem; 2011 Nov; 286(44):37976-37989. PubMed ID: 21832048 [TBL] [Abstract][Full Text] [Related]
16. Molecular modeling and structural analysis of nAChR variants uncovers the mechanism of resistance to snake toxins. Gunasekaran D; Sridhar J; Suryanarayanan V; Manimaran NC; Singh SK J Biomol Struct Dyn; 2017 Jun; 35(8):1654-1671. PubMed ID: 27421773 [TBL] [Abstract][Full Text] [Related]
17. Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes alpha4beta2 and alpha7. Bisson WH; Westera G; Schubiger PA; Scapozza L J Mol Model; 2008 Oct; 14(10):891-9. PubMed ID: 18607650 [TBL] [Abstract][Full Text] [Related]
18. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins. Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000 [TBL] [Abstract][Full Text] [Related]
19. Computer modeling of binding of diverse weak toxins to nicotinic acetylcholine receptors. Mordvitsev DY; Polyak YL; Kuzmin DA; Levtsova OV; Tourleigh YV; Utkin YN; Shaitan KV; Tsetlin VI Comput Biol Chem; 2007 Apr; 31(2):72-81. PubMed ID: 17392029 [TBL] [Abstract][Full Text] [Related]
20. Molecular docking study on the α3β2 neuronal nicotinic acetylcholine receptor complexed with α-conotoxin GIC. Lee C; Lee SH; Kim DH; Han KH BMB Rep; 2012 May; 45(5):275-80. PubMed ID: 22617450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]